| scholarly article | Q13442814 |
| P2093 | author name string | Cherniack RM | |
| Brown K | |||
| Schwarz MI | |||
| Colby TV | |||
| Flint A | |||
| King TE Jr | |||
| Waldron JA Jr | |||
| Tooze JA | |||
| Thurlbeck W | |||
| P2860 | cites work | Determinants of progression in idiopathic pulmonary fibrosis | Q23911352 |
| Determinants of survival in idiopathic pulmonary fibrosis | Q23911353 | ||
| Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis | Q28260133 | ||
| Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification | Q34066372 | ||
| Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine | Q34714909 | ||
| Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis | Q34737461 | ||
| Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study | Q34745971 | ||
| British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society | Q35563129 | ||
| Prognosis of cryptogenic fibrosing alveolitis | Q36128128 | ||
| Cryptogenic fibrosing alveolitis: clinical features and their influence on survival | Q36461325 | ||
| Circulating Immune Complexes in the Idiopathic Interstitial Pneumonias | Q39842066 | ||
| Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features | Q44403537 | ||
| Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. | Q50602679 | ||
| Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. | Q51041008 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| idiopathic pulmonary fibrosis | Q2290446 | ||
| P304 | page(s) | 1025-1032 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality | |
| P478 | volume | 164 |
| Q89565682 | A Rnd3/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts |
| Q46795700 | A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep. |
| Q42666339 | A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis |
| Q28266119 | A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis |
| Q47563113 | AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease |
| Q42482212 | Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis |
| Q37421300 | Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. |
| Q49917965 | Activated human T lymphocytes inhibit TGFβ-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2. |
| Q90220282 | Acute Lung Injury: IL-17A-Mediated Inflammatory Pathway and Its Regulation by Curcumin |
| Q38656594 | Advances in the treatment of idiopathic pulmonary fibrosis |
| Q60048978 | Airway remodeling disease: primary human structural cells and phenotypic and pathway assays to identify targets with potential to prevent or reverse remodeling |
| Q35600363 | Airway-centered interstitial fibrosis: etiology, clinical findings and prognosis |
| Q33875114 | Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis |
| Q28308246 | An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management |
| Q33960458 | Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo. |
| Q36790758 | Association Between Interstitial Lung Abnormalities and All-Cause Mortality |
| Q36197870 | Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis |
| Q34399563 | CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury |
| Q38480847 | CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner Society |
| Q35083577 | Carbon monoxide suppresses bleomycin-induced lung fibrosis |
| Q35741750 | Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-2002. A 56-year-old man with rapidly worsening dyspnea |
| Q47714359 | Cell profiles of bronchoalveolar lavage fluid as prognosticators of idiopathic pulmonary fibrosis/usual interstitial pneumonia among Japanese Patients |
| Q33244817 | Cell-specific gene expression in patients with usual interstitial pneumonia |
| Q38987215 | Chronic breathlessness in patients with idiopathic pulmonary fibrosis: a major challenge for caregivers |
| Q42168875 | Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs |
| Q24655062 | Classification and natural history of the idiopathic interstitial pneumonias |
| Q34156734 | Classification of idiopathic interstitial pneumonias: making sense of the alphabet soup |
| Q37799183 | Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis |
| Q33214781 | Clinical advances in the diagnosis and therapy of the interstitial lung diseases |
| Q53392680 | Clinical and functional outcomes in Middle Eastern patients with idiopathic pulmonary fibrosis. |
| Q35016822 | Clinical approach to interstitial lung disease |
| Q79180921 | Clinical comments on the new classification of diffuse interstitial lung diseases |
| Q36380992 | Clinical predictors of survival in idiopathic pulmonary fibrosis |
| Q34940632 | Comparison of usual interstitial pneumonia and nonspecific interstitial pneumonia: quantification of disease severity and discrimination between two diseases on HRCT using a texture-based automated system |
| Q78625867 | Compliance (COMmunicate PLease wIth Less Abbreviations, Noun Clusters, and Exclusiveness) |
| Q78050368 | Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis |
| Q36149399 | Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction |
| Q53180514 | Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. |
| Q39481263 | Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis. |
| Q37594222 | Determinants of initiation and progression of idiopathic pulmonary fibrosis |
| Q37778199 | Differentiating between IPF and NSIP. |
| Q47808263 | Disease severity staging system for idiopathic pulmonary fibrosis in Japan |
| Q80564943 | Distribution of CXCR3- or CCR4-positive cells in interstitial pneumonia associated with primary Sjogren's syndrome |
| Q34005597 | Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective |
| Q34554406 | Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis |
| Q40616834 | Downregulation of FAK-related non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts |
| Q46686864 | Drug treatments for idiopathic pulmonary fibrosis |
| Q80597495 | Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis |
| Q53088223 | EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis. |
| Q36013730 | Early interstitial lung disease in familial pulmonary fibrosis |
| Q56765460 | Emphysema and smoking-related lung diseases |
| Q37744240 | Endothelin in pulmonary fibrosis |
| Q55114038 | Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis. |
| Q33996286 | Epithelial origin of myofibroblasts during fibrosis in the lung |
| Q36427136 | Epithelial-mesenchymal interactions in pulmonary fibrosis |
| Q64085716 | Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk |
| Q43664371 | Evidence based respiratory medicine. 6th update workshop of SPLF March 30th, 2007. Interstitial lung diseases |
| Q24811876 | Expression of HSP47 in usual interstitial pneumonia and nonspecific interstitial pneumonia |
| Q36534222 | Extracellular superoxide dismutase in pulmonary fibrosis |
| Q30413255 | FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis |
| Q51683905 | Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. |
| Q37887074 | Fibrocytes and the tissue niche in lung repair |
| Q38106756 | Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature |
| Q33369846 | Fibrotic myofibroblasts manifest genome-wide derangements of translational control |
| Q36499388 | Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in Fibrosis |
| Q43008071 | Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner |
| Q35769497 | Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. |
| Q36027512 | From "traction bronchiectasis" to honeycombing in idiopathic pulmonary fibrosis: A spectrum of bronchiolar remodeling also in radiology? |
| Q33334369 | Functional Wnt signaling is increased in idiopathic pulmonary fibrosis |
| Q42823644 | Functional role and species-specific contribution of arginases in pulmonary fibrosis |
| Q35028793 | Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study |
| Q24804612 | Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts |
| Q38434667 | HRCT of fibrosing lung disease |
| Q37418285 | Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis |
| Q37580715 | High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis |
| Q37676977 | High-resolution computed tomography in the diagnosis and follow-up of idiopathic pulmonary fibrosis |
| Q36205965 | Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo |
| Q51716678 | Histopathology and prediction of survival in usual interstitial pneumonia. |
| Q36316053 | Host predisposition by endogenous Transforming Growth Factor-beta1 overexpression promotes pulmonary fibrosis following bleomycin injury |
| Q42465609 | Human lung parenchyma but not proximal bronchi produces fibroblasts with enhanced TGF-beta signaling and alpha-SMA expression. |
| Q35098429 | Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia |
| Q28272013 | IPF: new insight on pathogenesis and treatment |
| Q38821078 | Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways |
| Q92702927 | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs |
| Q34000433 | Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management |
| Q21202895 | Idiopathic pulmonary fibrosis |
| Q36440438 | Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy |
| Q45998315 | Idiopathic pulmonary fibrosis as a prognostic factor in non-small cell lung cancer. |
| Q57762744 | Idiopathic pulmonary fibrosis: An update |
| Q36726365 | Idiopathic pulmonary fibrosis: a decade of progress |
| Q27499290 | Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges |
| Q38205617 | Idiopathic pulmonary fibrosis: early detection and referral |
| Q39657805 | Idiopathic pulmonary fibrosis: immunohistochemical analysis provides fresh insights into lung tissue remodelling with implications for novel prognostic markers. |
| Q34962398 | Idiopathic pulmonary fibrosis: new insights in its pathogenesis |
| Q35669837 | Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches |
| Q61797496 | Idiopathic pulmonary fibrosis: prognostic impact of histologic honeycombing in transbronchial lung cryobiopsy |
| Q37110229 | Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. |
| Q35562827 | Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes |
| Q33783426 | Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis |
| Q36333459 | Improved In vivo Assessment of Pulmonary Fibrosis in Mice using X-Ray Dark-Field Radiography. |
| Q40261230 | In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung. |
| Q36222986 | Increased fibroblast telomerase expression precedes myofibroblast α-smooth muscle actin expression in idiopathic pulmonary fibrosis |
| Q36447387 | Increased lymphatic vessel length is associated with the fibroblast reticulum and disease severity in usual interstitial pneumonia and nonspecific interstitial pneumonia |
| Q98771879 | Inhibition of the SET8 Pathway Ameliorates Lung Fibrosis Even Through Fibroblast Dedifferentiation |
| Q57466140 | Inspiratory Lung Expansion in Patients with Interstitial Lung Disease: CT Histogram Analyses |
| Q35083605 | Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition |
| Q33551808 | Interaction of Src and Alpha-V Integrin Regulates Fibroblast Migration and Modulates Lung Fibrosis in A Preclinical Model of Lung Fibrosis |
| Q36256282 | Interferon gamma-1b in the treatment of idiopathic pulmonary fibrosis |
| Q90066593 | Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation |
| Q55312891 | Interstitial Lung Diseases Misdiagnosed as Tuberculosis. |
| Q90447883 | Intracellular Heat Shock Protein 70 Deficiency in Pulmonary Fibrosis |
| Q37230492 | JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers. |
| Q91620798 | LncRNA PFAR contributes to fibrogenesis in lung fibroblasts through competitively binding to miR-15a |
| Q35085070 | Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis |
| Q58710324 | Lung Transplantation in Idiopathic Pulmonary Fibrosis |
| Q36020530 | Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis. |
| Q35293795 | Lung transplantation. Recipient selection |
| Q26773022 | Lymphangiogenesis and Lesion Heterogeneity in Interstitial Lung Diseases |
| Q51768434 | MR imaging, targeting and characterization of pulmonary fibrosis using intra-tracheal administration of gadolinium-based nanoparticles. |
| Q36712749 | Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted |
| Q36744841 | Matrix-driven Myosin II Mediates the Pro-fibrotic Fibroblast Phenotype |
| Q34870967 | Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF. |
| Q34499296 | Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-β1. |
| Q48963871 | MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts |
| Q34356445 | MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix |
| Q35179655 | Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy |
| Q35083612 | Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. |
| Q37596487 | Molecular magnetic resonance imaging of pulmonary fibrosis in mice |
| Q64374937 | NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5 |
| Q37362597 | New perspectives in the treatment of idiopathic pulmonary fibrosis |
| Q37585596 | Non-invasive biomarkers in pulmonary fibrosis |
| Q37164198 | Notch1 signaling in FIZZ1 induction of myofibroblast differentiation |
| Q38725808 | Novel Drug Targets For Idiopathic Pulmonary Fibrosis. |
| Q39108878 | Optimizing quality of life in patients with idiopathic pulmonary fibrosis. |
| Q45984831 | Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis. |
| Q85769868 | Outstaying their Welcome: The Persistent Myofibroblast in IPF |
| Q41171992 | Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis |
| Q33824173 | Oxygen desaturation in healthy subjects undergoing the incremental shuttle walk test |
| Q42521125 | PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition |
| Q38034037 | Palliative and end-of-life care for patients with idiopathic pulmonary fibrosis: challenges and dilemmas |
| Q30366412 | Palliative care and location of death in decedents with idiopathic pulmonary fibrosis |
| Q33976506 | Pathogenesis of idiopathic pulmonary fibrosis |
| Q38222245 | Pathogenesis of idiopathic pulmonary fibrosis and its clinical implications |
| Q33607363 | Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. |
| Q35016824 | Pathologist's approach to diffuse lung disease |
| Q38698622 | Pathology of Idiopathic Interstitial Pneumonias. |
| Q35683018 | Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis |
| Q26771309 | Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives |
| Q23924071 | Phosphatidylinositol-3-Kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen production |
| Q28396403 | Pleural mesothelial cells in pleural and lung diseases |
| Q34687520 | Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia. |
| Q36793573 | Profibrotic role of WNT10A via TGF-β signaling in idiopathic pulmonary fibrosis |
| Q94333766 | Prognosis of adults with idiopathic pulmonary fibrosis without treatment or without effective therapies |
| Q43818482 | Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia |
| Q34769862 | Prognostic value of immunohistochemical surfactant protein A expression in regenerative/hyperplastic alveolar epithelial cells in idiopathic interstitial pneumonias |
| Q35219865 | Prostaglandin E2 and the pathogenesis of pulmonary fibrosis. |
| Q35543612 | Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction |
| Q36244231 | Pulmonary fibrosis |
| Q44623775 | Pulmonary fibrosis. Classification, diagnosis, therapy |
| Q36493952 | Pulmonary function testing in idiopathic interstitial pneumonias |
| Q47885073 | Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study |
| Q45350033 | Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis |
| Q64067283 | Quantitative CT analysis of honeycombing area predicts mortality in idiopathic pulmonary fibrosis with definite usual interstitial pneumonia pattern: A retrospective cohort study |
| Q38109606 | Quantitative microscopy of the lung: a problem-based approach. Part 2: stereological parameters and study designs in various diseases of the respiratory tract |
| Q34129022 | Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis |
| Q40356888 | Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. |
| Q33754678 | Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis |
| Q26743421 | Redox mechanisms in age-related lung fibrosis |
| Q37585592 | Rehabilitation and palliative care in lung fibrosis |
| Q35785641 | Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease |
| Q36225312 | Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia |
| Q37528351 | Relationship between survival and age in patients with idiopathic pulmonary fibrosis. |
| Q35016942 | Relevance analysis of clinical and lung function parameters changing and prognosis of idiopathic pulmonary fibrosis |
| Q35983620 | Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance |
| Q37389561 | Road ahead to respiratory health: experts chart future research directions. |
| Q28585044 | Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury |
| Q37473336 | Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype |
| Q37800646 | STAT3 in tissue fibrosis: Is there a role in the lung? |
| Q38026814 | STAT3: a central mediator of pulmonary fibrosis? |
| Q36271033 | Scoring of the radiological picture of idiopathic interstitial pneumonia: a study to verify the reliability of the method |
| Q47616378 | Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores |
| Q37277707 | Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. |
| Q47868546 | Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia |
| Q36634731 | Smad3 signaling involved in pulmonary fibrosis and emphysema |
| Q26795653 | Smoking and interstitial lung diseases |
| Q37377796 | Spectrum of fibrosing diffuse parenchymal lung disease |
| Q36862120 | Spiruchostatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis |
| Q43080091 | Stress in the ER (endoplasmic reticulum): a matter of life and death for epithelial cells |
| Q79151806 | Structural features of epithelial remodeling in usual interstitial pneumonia histologic pattern |
| Q52010647 | Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. |
| Q35621434 | Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis |
| Q24813751 | TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT) |
| Q51007434 | TGF-β1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts. |
| Q38159689 | TGF-β: Titan of Lung Fibrogenesis |
| Q37008372 | Targeting NOX enzymes in pulmonary fibrosis |
| Q38698660 | Targeting collagen for diagnostic imaging and therapeutic delivery |
| Q28387228 | Targeting the isoprenoid pathway to abrogate progression of pulmonary fibrosis |
| Q36138013 | Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. |
| Q35628585 | The bone marrow leaves its scar: new concepts in pulmonary fibrosis |
| Q36803302 | The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis |
| Q40024041 | The diagnosis of idiopathic pulmonary fibrosis and its complications |
| Q33924950 | The diagnosis of idiopathic pulmonary fibrosis: current and future approaches |
| Q33282713 | The effect of TGF-β1 and Smad7 gene transfer on the phenotypic changes of rat alveolar epithelial cells |
| Q36493978 | The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond |
| Q54974258 | The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis. |
| Q52602027 | The inhibition of human lung fibroblast proliferation and differentiation by Gs-coupled receptors is not predicted by the magnitude of cAMP response. |
| Q28391520 | The pleural mesothelium in development and disease |
| Q48318286 | The prognostic significance of pneumothorax in patients with idiopathic pulmonary fibrosis |
| Q37111866 | The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis |
| Q52941268 | The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. |
| Q38055449 | The role of dimethylarginine dimethylaminohydrolase (DDAH) in pulmonary fibrosis |
| Q42607396 | The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? |
| Q38088845 | The role of lung biopsy in the diagnosis and management of idiopathic interstitial pneumonia |
| Q34645189 | The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. |
| Q35942450 | Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis |
| Q27333960 | Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis |
| Q33991101 | Thy-1-integrin alphav beta5 interactions inhibit lung fibroblast contraction-induced latent transforming growth factor-beta1 activation and myofibroblast differentiation |
| Q36015454 | Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis |
| Q38367113 | Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis |
| Q35610196 | Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis. |
| Q34550149 | Tuberculosis, lung infections, interstitial lung disease, and socioeconomic issues in AJRCCM 2001. |
| Q39744350 | Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1. |
| Q48315576 | Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. |
| Q37596106 | Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis |
| Q36769703 | Update in diffuse parenchymal lung disease 2006. |
| Q51782313 | Update in diffuse parenchymal lung disease 2008. |
| Q28083944 | Update on therapeutic management of idiopathic pulmonary fibrosis |
| Q33556249 | Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts |
| Q47384446 | Validity of Ultrasound Lung Comets for Assessment of the Severity of Interstitial Pneumonia |
| Q24650922 | WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis |
| Q37056479 | X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis. |
| Q81523011 | [Evidence based pneumology: 3rd update workshop to the SPLF. Idiopathic diffuse interstitial pneumopathies] |
| Q79318003 | [Video-assisted diagnostic thoracoscopy] |
| Q92198051 | mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β1-induced collagen biosynthesis |
| Q90258614 | tPA promotes the proliferation of lung fibroblasts and activates the Wnt/β-catenin signaling pathway in idiopathic pulmonary fibrosis |
| Q58599362 | αvβ3 Integrin drives fibroblast contraction and strain stiffening of soft provisional matrix during progressive fibrosis |
Search more.